“
“
bio quotes
In order to meet its evergrowing demand for pulses,
India needs to achieve selfsufficiency in pulses. We need
to make pulses production
more profitable by reducing
production costs through
mechanization, using hybrids
and minimizing the postharvest losses.
Dr David Bergvinson, Director
General, ICRISAT on demand for
hybrid pigeonpea seeds
Obtaining DCGI approval for
Stempeucel is an important and
historic milestone. We are the
FIRST Company in India to
achieve such approval. It took
almost 9 years to develop
Stempeucel for the treatment of
Buerger’s Disease. Our goal is to
globalize Stempeucel for
Buerger’s Disease and the
market size is approx. US$ 1.5
Billion worldwide.
Mr B N Manohar, CEO,
Stempeutics on Stempeucel
becoming 5th off-the-shelf
approved stem cell in the world
50
BioVoiceNews | July 2016
“
“
India and Japan share a
common vision of a sustainable
future. The government of India
is committed to transforming
India into a knowledge-based
society and such collab